RecruitingNCT05995782
Official study titleA Phase 1, Randomized, Double-Blind, Placebo-Controlled, SAD and MAD Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral FB418 in Healthy Adult Subjects and Healthy Elderly Subjects
In SeoulSchizophreniaMedication studyAges 19+
- Countries
- South Korea
- Sponsor
- 1ST Biotherapeutics, Inc.
RecruitingNCT06911723
In BirminghamSchizophreniaBehavioural studyAges 18–65
- Countries
- United States
- Sponsor
- University of Alabama at Birmingham
RecruitingNCT06886945
In BresciaSchizophreniaObservational studyAges 18–50
- Countries
- Italy
- Sponsor
- IRCCS Centro San Giovanni di Dio Fatebenefratelli
RecruitingNCT05384392
Official study titleBiomarkers Predictive of Thymic Evolution and Therapeutic Response at 2 Years in Patients With a First Psychotic Episode
Multiple locations, including AngersSchizophreniaStudy assessmentsAges 15–30
- Countries
- France
- Sponsor
- University Hospital, Brest
RecruitingNCT05357612
Official study titleCharacterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases
In NashvilleSchizophreniaMedication studyAges 50–85
- Countries
- United States
- Sponsor
- Vanderbilt University Medical Center
RecruitingNCT07658898
Official study titleA Randomized Controlled Trial Exploring the Efficacy of Temporal Interference Stimulation for Negative Symptoms and Cognitive Impairment in Schizophrenia
In ShanghaiSchizophreniaDevice studyAges 18–65
- Countries
- China
- Sponsor
- Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University
RecruitingNCT07113119
In ThessalonikiSchizophreniaInterventional studyAges 18+
- Countries
- Greece
- Sponsor
- Aristotle University Of Thessaloniki
RecruitingNCT05185128
Official study titleNeural Basis of Social Cognition Deficits in Youth With Autism and Schizophrenia
In Loma LindaSchizophreniaBehavioural studyAges 12–18
- Countries
- United States
- Sponsor
- Loma Linda University
RecruitingNCT07459270
Official study titleInvestigation of Factors Associated With Psychiatric Symptoms in Participants Diagnosed With Methamphetamine-Induced Psychotic Disorder With and Without Lifetime Cannabis Use
In ElâzığSchizophreniaObservational studyAges 18–65
- Countries
- Türkiye
- Sponsor
- Elazığ Mental Health and Diseases Hospital
RecruitingNCT07459257
Official study titleInvestigation of Factors Associated With Psychiatric Symptoms in Methamphetamine-Induced Psychotic Disorder: One-Year Longitudinal Study
In ElâzığSchizophreniaObservational studyAges 18–65
- Countries
- Türkiye
- Sponsor
- Elazığ Mental Health and Diseases Hospital
RecruitingNCT07671261
Official study titleDeep Brain Stimulation for Treatment-Refractory Schizophrenia: Individualized Target Selection and Efficacy
In ShanghaiSchizophreniaDevice studyAges 18–55
- Countries
- China
- Sponsor
- Ruijin Hospital
RecruitingNCT05951660
Official study titleThe Effect of Targeted Education on Number, Severity, and Perception of Sexual Side Effects of Patients Suffering From Schizophrenia and Diabetes or Prediabetes.
In SlagelseSchizophreniaBehavioural studyAges 18+
- Countries
- Denmark
- Sponsor
- Zealand University Hospital
Data coveragePublic registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.